Evidence map›Paper›PMID 35102304›Full record

ArticleNature microbiology2022

Histone acetylome-wide associations in immune cells from individuals with active Mycobacterium tuberculosis infection.

Ricardo C H Del Rosario, Jeremie Poschmann, Carey Lim, Catherine Y Cheng, Pavanish Kumar, Catherine Riou, Seow Theng Ong, Sherif Gerges, Hajira Shreen Hajan, Dilip Kumar and 20 more

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Nature microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. mBio · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Altered histone modifications inbioRxiv : the preprint server for biology · 2025
    Article
  9. AProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. microLife · 2023
    Article
  15. The role ofFrontiers in cellular and infection microbiology · 2023
    Review
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

30 authors at 6 institutions in 6 countries.

Ricardo C H Del Rosario *Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.ORCID http://orcid.org/0000-0002-7038-9598
Jeremie Poschmann *Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.ORCID http://orcid.org/0000-0002-9613-5297
Carey Lim *Singapore Immunology Network, A*STAR, Singapore, Singapore.
Catherine Y Cheng *Singapore Immunology Network, A*STAR, Singapore, Singapore.
Pavanish KumarSingapore Immunology Network, A*STAR, Singapore, Singapore.ORCID http://orcid.org/0000-0003-1832-4436
Catherine RiouWellcome Centre for Infectious Diseases Research in Africa, University of Cape Town, Cape Town, South Africa.ORCID http://orcid.org/0000-0001-9679-0745
Seow Theng OngLee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.ORCID http://orcid.org/0000-0001-6089-4745
Sherif GergesStanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Hajira Shreen HajanGenome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
Dilip KumarInserm, Université de Nantes, Centre de Recherche en Transplantation et Immunologie, ITUN, Nantes, France.ORCID http://orcid.org/0000-0002-1848-3034
Mardiana MarzukiSingapore Immunology Network, A*STAR, Singapore, Singapore.
Xiaohua LuSingapore Immunology Network, A*STAR, Singapore, Singapore.
Andrea LeeSingapore Immunology Network, A*STAR, Singapore, Singapore.
Giovani Claresta WijayaGenome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
Nirmala Arul RayanGenome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
Zhong ZhuangLee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
Elsa Du BruynWellcome Centre for Infectious Diseases Research in Africa, University of Cape Town, Cape Town, South Africa.
Cynthia Bin Eng CheeTuberculosis Control Unit, Tan Tock Seng Hospital, Singapore, Singapore.
Bernett LeeSingapore Immunology Network, A*STAR, Singapore, Singapore.
Josephine LumSingapore Immunology Network, A*STAR, Singapore, Singapore.ORCID http://orcid.org/0000-0003-1108-5989
Francesca ZolezziSingapore Immunology Network, A*STAR, Singapore, Singapore.
Michael PoidingerSingapore Immunology Network, A*STAR, Singapore, Singapore.ORCID http://orcid.org/0000-0002-1047-2277
Olaf RotzschkeSingapore Immunology Network, A*STAR, Singapore, Singapore.ORCID http://orcid.org/0000-0001-8336-5248
Chiea Chuen KhorGenome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.ORCID http://orcid.org/0000-0002-1128-4729
Robert J WilkinsonWellcome Centre for Infectious Diseases Research in Africa, University of Cape Town, Cape Town, South Africa.
Yee T WangTuberculosis Control Unit, Tan Tock Seng Hospital, Singapore, Singapore.
George K ChandyLee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
Gennaro De LiberoSingapore Immunology Network, A*STAR, Singapore, Singapore.
Amit SinghalSingapore Immunology Network, A*STAR, Singapore, Singapore. amit_singhal@idlabs.a-star.edu.sg.
Shyam PrabhakarGenome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore. prabhakars@gis.a-star.edu.sg.ORCID http://orcid.org/0000-0002-6409-0661
Agency for Science, Technology and Research · SGNanyang Technological University · SGUniversity of Cape Town · ZABroad Institute · USTan Tock Seng Hospital · SGInserm · FR

Funding

Efficacy and cost of HAART DOT in methadone clinicsR01DA015302 · NIDA · YESHIVA UNIVERSITY · PI ARNSTEN, JULIA H · 2003 to 2007
$4.8M
Inflammatory determinants of disease severity and treatment outcome in TB patientsU01AI115940 · NIAID · UNIVERSITY OF CAPE TOWN · PI SHER, ALAN, WILKINSON, ROBERT JOHN · 2015 to 2019
$1.1M
Cancer Research UK FC0012018Medical Research Council FC0012018NIAID NIH HHS U01 AI115940NIDA NIH HHS R01 DA015302Wellcome TrustWellcome Trust 104803Wellcome Trust 203135Wellcome Trust FC0012018
6 · The paper itself

Abstract

Host cell chromatin changes are thought to play an important role in the pathogenesis of infectious diseases. Here we describe a histone acetylome-wide association study (HAWAS) of an infectious disease, on the basis of genome-wide H3K27 acetylation profiling of peripheral blood granulocytes and monocytes from persons with active Mycobacterium tuberculosis (Mtb) infection and healthy controls. We detected >2,000 differentially acetylated loci in either cell type in a Singapore Chinese discovery cohort (n = 46), which were validated in a subsequent multi-ethnic Singapore cohort (n = 29), as well as a longitudinal cohort from South Africa (n = 26), thus demonstrating that HAWAS can be independently corroborated. Acetylation changes were correlated with differential gene expression. Differential acetylation was enriched near potassium channel genes, including KCNJ15, which modulates apoptosis and promotes Mtb clearance in vitro. We performed histone acetylation quantitative trait locus (haQTL) analysis on the dataset and identified 69 candidate causal variants for immune phenotypes among granulocyte haQTLs and 83 among monocyte haQTLs. Our study provides proof-of-principle for HAWAS to infer mechanisms of host response to pathogens.

Indexed as

Genetic Association StudiesAcetylationAdultChromatinCohort StudiesFemaleGranulocytesHistonesHumansLongitudinal StudiesMaleMonocytesMycobacterium tuberculosisProof of Concept StudyQuantitative Trait LociSingaporeChromatinHistones

Identifiers

PMID35102304
PMCPMC9439955
OpenAlexW4210472863

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.